Prognostic factors for survival and radiation necrosis after stereotactic radiosurgery alone or in combination with whole brain radiation therapy for 1-3 cerebral metastases

Radiation Oncology

Volumn 9, Issue 1, 2014, Pages

  Schüttrumpf, Lars H ^a   Niyazi, Maximilian ^a   Nachbichler, Silke B ^a   Manapov, Farkhad ^a   Jansen, Nathalie ^a   Siefert, Axel ^b   Belka, Claus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Klinikum Schwabing   (Germany)

Author keywords

Cerebral metastases; Radiation necrosis; Radiosurgery; Stereotactic radiotherapy

Indexed keywords

AGED; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER PROGNOSIS; CANCER RADIOTHERAPY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HUMAN; KARNOFSKY PERFORMANCE STATUS; KIDNEY CARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; RADIATION NECROSIS; RETROSPECTIVE STUDY; STEREOTACTIC RADIOSURGERY; TREATMENT PLANNING; BRAIN NEOPLASMS; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NECROSIS; NEOPLASMS; PATHOLOGY; PROGNOSIS; RADIATION DOSE; RADIATION INJURIES; RADIOSURGERY; SECONDARY; SKULL IRRADIATION; SURVIVAL RATE;

AGED; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NECROSIS; NEOPLASM STAGING; NEOPLASMS; PROGNOSIS; RADIATION INJURIES; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84901641817     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-9-105     Document Type: Article

References (27)

1. Khuntia D, Brown P, Li J, Mehta MP. Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 2006, 24(8):1295-1304. 10.1200/JCO.2005.04.6185, 16525185.
2. Meisner J, Meyer A, Polivka B, Karstens JH, Bremer M. Outcome of moderately dosed radiosurgery for limited brain metastases: report of a single-center experience. Strahlenther Onkol 2010, 186(2):76-81. 10.1007/s00066-010-2036-2, 20127224.
3. D'Agostino GR, Autorino R, Pompucci A, De Santis MC, Manfrida S, Di Lella G, Mantini G, Frascino V, Chiesa S, Albanese A, Dinapoli N, Azario L, Fiorentino A, Valentini V, Anile C, Balducci M. Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. Strahlenther Onkol 2011, 187(7):421-425. 10.1007/s00066-011-2228-4, 21713390.
4. Auchter RM, Lamond JP, Alexander E, Buatti JM, Chappell R, Friedman WA, Kinsella TJ, Levin AB, Noyes WR, Schultz CJ, Loeffler JS, Mehta MP. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 1996, 35(1):27-35. 10.1016/S0360-3016(96)85008-5, 8641923.
5. Kocher M, Maarouf M, Bendel M, Voges J, Muller RP, Sturm V. Linac radiosurgery versus whole brain radiotherapy for brain metastases: a survival comparison based on the RTOG recursive partitioning analysis. Strahlenther Onkol 2004, 180(5):263-267. 10.1007/s00066-004-1180-y, 15127155.
6. Rades D, Pluemer A, Veninga T, Hanssens P, Dunst J, Schild SE. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases. Cancer 2007, 110(10):2285-2292. 10.1002/cncr.23037, 17922523.
7. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006, 295(21):2483-2491. 10.1001/jama.295.21.2483, 16757720.
8. Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 2011, 29(2):134-141. 10.1200/JCO.2010.30.1655, 3058272, 21041710.
9. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, Markesbery WR, Foon KA, Young B. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998, 280(17):1485-1489.
10. Tsao MN, Lloyd N, Wong RK, Chow E, Rakovitch E, Laperriere N, Xu W, Sahgal A. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev 2012, 4. CD003869.
11. Lawrence YR, Li XA, el Naqa I, Hahn CA, Marks LB, Merchant TE, Dicker AP. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 2010, 76(3 Suppl):S20-S27. 3554255, 20171513.
12. Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2010, 77(4):996-1001. 10.1016/j.ijrobp.2009.06.006, 19783374.
13. Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A, Romano A, Enrici RM. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 2011, 6:48. 10.1186/1748-717X-6-48, 3108308, 21575163.
14. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000, 47(2):291-298. 10.1016/S0360-3016(99)00507-6, 10802351.
15. Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. Br J Cancer 1995, 72(2):511-518. 10.1038/bjc.1995.364, 2033978, 7640241.
16. Sneed PK, Suh JH, Goetsch SJ, Sanghavi SN, Chappell R, Buatti JM, Regine WF, Weltman E, King VJ, Breneman JC, Sperduto PW, Mehta MP. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 2002, 53(3):519-526. 10.1016/S0360-3016(02)02770-0, 12062592.
17. Pirzkall A, Debus J, Lohr F, Fuss M, Rhein B, Engenhart-Cabillic R, Wannenmacher M. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 1998, 16(11):3563-3569.
18. Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Mueller RP, Tridello G, Collette L, Bottomley A. A European organisation for research and treatment of cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 2013, 31(1):65-72. 10.1200/JCO.2011.41.0639, 23213105.
19. Soussain C, Ricard D, Fike JR, Mazeron JJ, Psimaras D, Delattre JY. CNS complications of radiotherapy and chemotherapy. Lancet 2009, 374(9701):1639-1651. 10.1016/S0140-6736(09)61299-X, 19897130.
20. Frazier JL, Batra S, Kapor S, Vellimana A, Gandhi R, Carson KA, Shokek O, Lim M, Kleinberg L, Rigamonti D. Stereotactic radiosurgery in the management of brain metastases: an institutional retrospective analysis of survival. Int J Radiat Oncol Biol Phys 2010, 76(5):1486-1492. 10.1016/j.ijrobp.2009.03.028, 19619958.
21. Williams BJ, Suki D, Fox BD, Pelloski CE, Maldaun MV, Sawaya RE, Lang FF, Rao G. Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J Neurosurg 2009, 111(3):439-448. 10.3171/2008.11.JNS08984, 19301968.
22. Lutterbach J, Cyron D, Henne K, Ostertag CB. Radiosurgery followed by planned observation in patients with one to three brain metastases. Neurosurgery 2003, 52(5):1066-1073. discussion 1073-1064, 10.1227/01.NEU.0000057695.46198.FE, 12699548.
23. Galldiks N, Stoffels G, Filss CP, Piroth MD, Sabel M, Ruge MI, Herzog H, Shah NJ, Fink GR, Coenen HH, Langen KJ. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis. J Nucl Med 2012, 53(9):1367-1374. 10.2967/jnumed.112.103325, 22872742.
24. Voges J, Treuer H, Sturm V, Buchner C, Lehrke R, Kocher M, Staar S, Kuchta J, Muller RP. Risk analysis of linear accelerator radiosurgery. Int J Radiat Oncol Biol Phys 1996, 36(5):1055-1063. 10.1016/S0360-3016(96)00422-1, 8985027.
25. Korytko T, Radivoyevitch T, Colussi V, Wessels BW, Pillai K, Maciunas RJ, Einstein DB. 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys 2006, 64(2):419-424. 10.1016/j.ijrobp.2005.07.980, 16226848.
26. Shaw E, Scott C, Souhami L, Dinapoli R, Bahary JP, Kline R, Wharam M, Schultz C, Davey P, Loeffler J, Del Rowe J, Marks L, Fisher B, Shin K. Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05). Int J Radiat Oncol Biol Phys 1996, 34(3):647-654. 10.1016/0360-3016(95)02106-X, 8621289.
27. Valery CA, Cornu P, Noel G, Duyme M, Boisserie G, Sakka LJ, Mazeron JJ, van Effenterre R. Predictive factors of radiation necrosis after radiosurgery for cerebral metastases. Stereotact Funct Neurosurg 2003, 81(1-4):115-119.